# Microbiome Shift in Peri-mucositis by Anti-inflammatory Drugs

> **NCT03090009** · EARLY_PHASE1 · UNKNOWN · sponsor: **Polak David** · enrollment: 100 (estimated)

## Conditions studied

- Peri-implant Mucositis

## Interventions

- **DRUG:** Flurbiprofen
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03090009
- **Lead sponsor:** Polak David
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04
- **Primary completion:** 2019-04
- **Final completion:** 2020-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090009, "Microbiome Shift in Peri-mucositis by Anti-inflammatory Drugs". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03090009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*